相关实验视频

Updated: Jan 14, 2026

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

针对EGFR的铁酸激酶抑制剂:癌症治疗的进展

Shaheen Ali^1,2, Anam Ilyas², Shagufi Nazar²

¹Department of Molecular Medicine, School of Interdisciplinary Sciences and Technology, Jamia Hamdard, New Delhi, 110062, India.

Naunyn-Schmiedeberg's archives of pharmacology

|October 27, 2025

概括

以表皮生长因子受体 (EGFR) 为向的疗法,包括氨酸激酶抑制剂 (TKI),正在彻底改变癌症治疗. 纳米技术为克服EGFR向治疗的耐药性和减少毒性提供了解决方案.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
纳米技术纳米技术

背景情况:

表皮生长因子受体 (EGFR) 向疗法,特别是氨酸激酶抑制剂 (TKI),已经改变了非小细胞肺癌 (NSCLC) 治疗.
获得的耐药性,特别是T790M突变,以及非向性毒性仍然是EGFR向性治疗的重大挑战.
EGFR的作用超出了NSCLC的范围,在头和结直肠癌中已证明有效.

研究的目的:

审查EGFR在癌症治疗中的意义以及EGFR向性TKI的演变.
讨论与EGFR向疗法相关的抗药机制和毒性相关的挑战.
探索基于纳米技术的药物输送系统的进步,以加强EGFR向治疗.

主要方法:

关于EGFR向疗法,耐药性机制和纳米技术在药物输送中的应用的当前文献的综述.
分析基因组分析如何为瘤学中的精准医学方法提供信息.
探索基于纳米粒子的药物递送系统 (聚合基,PLGA,基) 以改善EGFR TKI的药理动力学和克服耐药性.

主要成果:

针对EGFR的TKIs通过阻断特定瘤生长途径,为传统化疗提供了更精确的替代方案.
纳米粒子增强药物溶解性,生物可用性和EGFRTKI的持续释放,从而降低毒性.
聚合物和无机纳米粒子在改善药理动力学和向输送方面具有潜力,这对于克服耐药性至关重要.

结论:

基于纳米技术的药物输送提供了有希望的解决方案,以克服获得的耐药性和减少EGFR向癌症治疗中的毒性.
药物输送,组合疗法和理解耐药机制方面的进展对于改善治疗结果至关重要.
个性化瘤学受益于将基因组分析与先进的向疗法和新型药物输送系统相结合.

关键词:

欧洲农业基金会 (EGFR) 是一个.纳米颗粒是指一个纳米粒子.在瘤学瘤学.这就是TKK的意思.TK 抑制剂的使用方法

更多相关视频

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...